ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026

Metabolic Response to CDK4/6 Inhibition in ER+ Breast Cancer Creates a Therapeutic Vulnerability in Drug-Tolerant Persister Cells.

Huijuan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.